Finnish healthcare group Mehiläinen, owned by CVC Capital Partners, which announced the acquisition of Regina Maria, must comply with several commitments negotiated with the Romanian Competition Council in order to secure approval for the deal. The authority reviewed the operation and concluded that it could affect competition in the market for assisted human reproduction services, potentially leading to price increases.
To address these concerns, Mehiläinen Oy agreed to a series of obligations. For three years, the company will cap prices for assisted reproduction procedures offered in clinics located in Bucharest, Brașov and Constanța, except for adjustments linked to annual inflation or justified cost changes such as taxes or doctors’ fees.
Additionally, Regina Maria will not bundle or tie assisted reproduction services with other medical services, nor will it promote commercial strategies based on more expensive combined packages. Any discount applied to packages that include assisted reproduction procedures and other Regina Maria services must also be available to patients who choose to purchase the services separately. An independent Monitoring Trustee, approved by the Competition Council, will verify compliance each year.
These commitments apply for three years from the closing date or until CVC funds no longer hold control over Regina Maria or any competing clinic in Bucharest or Brașov.
The landmark deal reshaping the regional medical market
Mehiläinen Group, a healthcare provider with a 115-year history and operations across five European countries, is behind the largest medical transaction in Central and Eastern Europe. Current owner Mid Europa Partners has sold 100% of Regina Maria and MediGroup, Serbia’s leading private healthcare operator.
The value of the deal remains undisclosed, though market sources indicate that Mid Europa Partners sought around one billion euros. Mehiläinen operates more than 890 clinics and employs over 37,000 professionals, reporting revenues of €2.06 billion in 2024.
Under Mid Europa’s ownership, Regina Maria expanded rapidly: from 3 to 8 hospitals, 19 to 53 polyclinics, and 9 to 37 laboratories, with investments exceeding €250 million. Today, the network includes 300 facilities and over 11,000 employees.
Photo: Helsingin Sanomat
